Abstract

Compass Minerals will report fiscal third-quarter results on August 05, 2026 Post Market. This preview consolidates the latest quarterly actuals, current-quarter forecasts, and media and analyst commentary since January 01, 2026, to frame expectations for revenue, profitability, segment trends, and likely market debate into the print.

Market Forecast

Consensus modeled in the finance tool implies current-quarter revenue of 206.67 million US dollars, down 3.43% year over year, with forecast EBIT of 13.00 million and forecast EPS of -0.06; year-over-year growth ratios for these forecasts translate to EBIT up 8.33% and EPS improving 43.18% from the prior-year loss. No explicit consensus gross margin or net margin is provided for the current quarter. The company’s main business is Salt, alongside North America Plant Nutrition and a small Corporate and Other line; Salt remains the core driver, while Plant Nutrition is the focus area for mix improvement.

Within the portfolio, Salt contributed 382.60 million US dollars last quarter, North America Plant Nutrition 67.00 million, and Corporate and Other 3.60 million. Plant Nutrition carries the largest upside optionality on a smaller base due to pricing and volume normalization through the agricultural season; Salt remains volume-heavy and seasonally sensitive.

Last Quarter Review

Last quarter, revenue was 453.20 million US dollars; gross profit margin was 18.31%; GAAP net profit attributable to shareholders was 12.70 million US dollars with a net margin of 2.80%; adjusted EPS was 0.66, up 4.76% year over year. Quarter-on-quarter, GAAP net profit declined 31.72% based on the ran_on_month_change field.

The quarter demonstrated resilient EBIT of 56.00 million, which exceeded year-ago levels, while revenue contracted 8.37% year over year, suggesting disciplined cost control amid softer top line. Segment-wise, Salt delivered 382.60 million US dollars and Plant Nutrition 67.00 million; Plant Nutrition’s growth vector was limited by the seasonal cadence, while Salt anchored cash generation.

Current Quarter Outlook

Main business: Salt

Salt is the largest revenue contributor and the key swing factor for quarterly results. For the current quarter, the consolidated revenue forecast of 206.67 million US dollars implies a seasonally softer period versus the winter-heavy prior quarter, and the year-over-year decline of 3.43% aligns with a normalized deicing season following the prior-year weather pattern. Margin evolution in Salt will likely hinge on logistics and production efficiency; with the prior quarter’s gross margin at 18.31%, investors will watch whether lower-volume throughput and freight costs pressure unit margins. Pricing discipline in highway deicing bids and steady consumer/industrial salt trends should mitigate volume variability, but weather and contract timing remain the principal determinants of realized profitability in this segment.

Most promising business: North America Plant Nutrition

Plant Nutrition, at 67.00 million US dollars last quarter, remains the smaller contributor but a focal point for incremental growth relative to its base. The current quarter sits within the agricultural application cycle in parts of North America; demand recovery and price stabilization can lift revenue and help mix. An improving earnings trajectory is suggested at the consolidated level by the forecast EPS of -0.06, which, despite being negative, represents a 43.18% year-over-year improvement and an 8.33% year-over-year increase in EBIT, indicating operating leverage potential if Plant Nutrition volumes and pricing hold. Investors will also watch working-capital release from this segment as inventories normalize through the season.

Key stock-price drivers this quarter

The market will focus on three profit drivers: revenue realization versus the 206.67 million US dollars forecast, EBIT conversion versus the 13.00 million target, and progress on cost and logistics efficiency after the 18.31% gross margin baseline. Any deviation in winter bid pricing flow-through to the shoulder season, alongside freight and energy input trends, may shift gross margin trajectory. The expected improvement in EPS on a year-over-year basis, even with a small loss forecast, will frame sentiment around turnaround momentum; confirmation of mix improvement from Plant Nutrition could reduce earnings volatility into fiscal year-end.

Analyst Opinions

Across recent previews and commentary, the prevailing stance is cautious. The distribution of views is skewed toward the bearish/cautious side versus bullish, reflecting expectations for a modest year-over-year revenue decline alongside margin sensitivity to weather, freight, and energy inputs. Notably, consensus embeds a small loss for the quarter with EPS of -0.06 and revenue of 206.67 million US dollars, suggesting limited near-term catalysts. The majority viewpoint emphasizes monitoring execution on Salt cost efficiency and stability in Plant Nutrition pricing to validate the improving EBIT trajectory. Institutions highlight that while EBIT is forecast to rise 8.33% year over year, the overall profitability profile remains exposed to seasonality, keeping positioning measured into August 05, 2026.